Johnson Financial Group LLC (Colorado)’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Johnson Financial Group LLC (Colorado)’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-250,000	Closed	-$50K	–	43
2022 Q4	$50K	Hold	250,000	–	–	0.01%	37
2022 Q3	$180K	Hold	250,000	–	–	0.02%	46
2022 Q2	$132K	Hold	250,000	–	–	0.03%	48
2022 Q1	$220K	Buy	+250,000	New	+$278K	0.04%	42

Other funds holding DNA.WS

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

JRCM

Jones Road Capital Management New York $55.3M AUM 29.97% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return

Johnson Financial Group LLC (Colorado)'s DNA.WS Position: Q1 2023 in Review

Johnson Financial Group LLC (Colorado) sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q1 2023, closing a stake of 250,000 shares — an estimated $50K sold.

Johnson Financial Group LLC (Colorado) first reported a position in DNA.WS in Q1 2022 and held it in 4 quarters. The position peaked at $220K in Q1 2022. 40 funds tracked by Wall St. Rank hold DNA.WS as of Q1 2023.

Johnson Financial Group LLC (Colorado) reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q1 2023 after selling out during the quarter.
Johnson Financial Group LLC (Colorado) sold 250,000 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q1 2023, an estimated $50K.
Johnson Financial Group LLC (Colorado) first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q1 2022 and held it in 4 quarters.
Johnson Financial Group LLC (Colorado)'s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $220K in Q1 2022.
40 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q1 2023.

Based on Johnson Financial Group LLC (Colorado)'s 13F filing for Q1 2023, filed 9 May 2023.